Entelo Bio

Entelo Bio is an Oxford-based biotechnology company developing a proprietary single-cell isoform sequencing and AI platform to decode disease biology in conditions affecting human movement and ageing.

Built on research from the University of Oxford's Botnar Institute for Musculoskeletal Sciences, the platform combines long-read RNA sequencing with machine learning to reveal hidden isoform-level biology and identify precision medicine targets.

Target disease areas include chronic musculoskeletal conditions, age-related movement disorders, and rare genetic diseases.